SOFINEL – A New Product in Arterium’s Portfolio
Arterium continues to implement innovative solutions and expand its capabilities in supporting patients’ psycho-emotional well-being. Recently, a new dietary supplement in capsule form – Sofinel – was launched on the Ukrainian market.
What makes Sofinel unique
The key ingredient of the dietary supplement Sofinel is the encapsulated saffron extract Safr’InsideTM at a dosage of 30 mg, which helps alleviate anxiety and psycho-emotional tension related to functional nervous system disorders. Thanks to an innovative extraction process, Safr’InsideTM preserves the saffron’s native active compounds in Sofinel’s formula.
“The uniqueness of Safr’InsideTM lies in maintaining a high concentration of saffron’s active ingredients – safranal and crocins, which are present in concentrations up to 10 times higher than in non-encapsulated extracts. According to survey results*, the anti-anxiety effect is noticeable within 30 minutes after taking a 30 mg dosage of Safr’InsideTM. Moreover, the encapsulated saffron extract Safr’InsideTM in a dosage of 30 mg in the composition of Sofinel in the survey* demonstrated its ability to alleviate anxiety, improve psycho-emotional well-being, and normalize sleep in patients with elevated anxiety levels,” said Oleksandr Kononenko, Product Development Manager at Arterium.
About the manufacturers
The encapsulated saffron extract is produced by Activ’Inside (France), a company specializing in the production of extracts with a maximum concentration of active ingredients. The Sofinel supplement is manufactured at Kyivmedpreparat facilities.
This is not the first dietary supplement launched on the Ukrainian market under the Arterium trademark in 2025. Earlier, we introduced the dietary supplement Sedavit® Uno, which expanded the Sedavit® product line.
*Link to the survey: https://www.mdpi.com/2072-6643/15/13/2921